Pharma Deko Plc (NGX:PHARMDEKO)
1.830
0.00 (0.00%)
At close: Mar 9, 2026
Pharma Deko Ratios and Metrics
Market cap in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Market Capitalization | 397 | 456 | 477 | 325 | 325 | 325 | Upgrade
|
| Market Cap Growth | -0.05% | -4.54% | 46.67% | - | -0.00% | -36.44% | Upgrade
|
| Enterprise Value | 419 | 479 | 456 | -26 | 339 | 314 | Upgrade
|
| Last Close Price | 1.83 | 2.10 | 2.20 | 1.50 | 1.50 | 1.50 | Upgrade
|
| PS Ratio | 0.84 | 0.97 | 0.95 | 0.71 | 0.67 | 0.32 | Upgrade
|
| PB Ratio | 0.39 | 0.45 | 0.37 | 0.33 | 0.25 | 0.21 | Upgrade
|
| P/TBV Ratio | 0.39 | 0.45 | 0.37 | 0.33 | 0.25 | 0.21 | Upgrade
|
| P/FCF Ratio | - | - | - | 3.13 | 120.03 | - | Upgrade
|
| P/OCF Ratio | - | - | - | 3.11 | 120.03 | - | Upgrade
|
| EV/Sales Ratio | 0.89 | 1.02 | 0.91 | - | 0.70 | 0.31 | Upgrade
|
| EV/FCF Ratio | -12.55 | - | - | - | 124.90 | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.13 | 5.53 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.02 | 0.02 | -0.02 | -0.10 | 0.01 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.10 | -0.10 | 0.48 | 0.37 | -0.03 | -0.07 | Upgrade
|
| Net Debt / FCF Ratio | -0.66 | -0.66 | 0.30 | -0.91 | 3.26 | -0.19 | Upgrade
|
| Asset Turnover | 0.21 | 0.21 | 0.23 | 0.22 | 0.21 | 0.45 | Upgrade
|
| Inventory Turnover | 2.23 | 2.23 | 2.32 | 1.73 | 1.15 | 2.62 | Upgrade
|
| Quick Ratio | 0.06 | 0.06 | 0.07 | 0.15 | 0.22 | 0.42 | Upgrade
|
| Current Ratio | 0.21 | 0.21 | 0.29 | 0.35 | 0.73 | 0.94 | Upgrade
|
| Return on Equity (ROE) | -25.54% | -25.54% | -6.08% | -28.31% | -19.22% | -15.92% | Upgrade
|
| Return on Assets (ROA) | -7.80% | -7.80% | -3.21% | -9.64% | -9.96% | -6.94% | Upgrade
|
| Return on Invested Capital (ROIC) | -25.68% | -24.59% | -10.25% | -29.39% | -24.66% | -15.31% | Upgrade
|
| Return on Capital Employed (ROCE) | -26.60% | -26.60% | -8.20% | -32.40% | -23.10% | -14.40% | Upgrade
|
| Earnings Yield | -74.65% | -65.02% | -14.62% | -99.94% | -85.71% | -81.52% | Upgrade
|
| FCF Yield | -8.41% | -7.32% | -14.57% | 31.92% | 0.83% | -19.80% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.61% | -0.96% | 0.57% | -3.50% | Upgrade
|
| Total Shareholder Return | - | - | 0.61% | -0.96% | 0.57% | -3.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.